Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Zeder, K; Marsh, LM; Avian, A; Brcic, L; Birnhuber, A; Douschan, P; Foris, V; Sassmann, T; Hoetzenecker, K; Boehm, PM; Kwapiszewska, G; Olschewski, A; Olschewski, H; Kovacs, G.
Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
J Heart Lung Transplant. 2024; 43(7):1090-1101 Doi: 10.1016/j.healun.2024.02.1044
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Olschewski Horst
Zeder Katarina Eleonora
Co-authors Med Uni Graz
Avian Alexander
Birnhuber Anna
Brcic Luka
Douschan Philipp
Foris Vasile
John Teresa
Kovacs Gabor
Kwapiszewska-Marsh Grazyna
Marsh Leigh
Olschewski Andrea
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: In patients with end-stage chronic obstructive pulmonary disease (COPD), severe pulmonary hypertension (PH) is frequently associated with less severe airway obstruction as compared to mild or no PH. However, the histologic correlate of this finding is not clear. We aimed to quantify remodeling of pulmonary arteries, airways, and parenchyma in random samples of explanted end-stage COPD lungs. METHODS: We quantified remodeling of small pulmonary arteries, small airways, and the degree of emphysema (mean interseptal distance [MID]) with dedicated software. As primary objective, we compared COPD patients with severe PH (SevPH-COPD) with age- and sex-matched MildPH-COPD. For comparison, we also investigated COPD lungs with no PH (NoPH-COPD), idiopathic PAH (IPAH), and healthy donors. RESULTS: We included n = 17 SevPH-COPD (mPAP = 43 [39-45]mm Hg), n = 17 MildPH-COPD (mPAP = 28 [24-31]mm Hg), n = 5 NoPH-COPD (mPAP = 18 [16-19]mm Hg), n = 10 IPAH (mPAP = 72 [65-91]mm Hg), and n = 10 healthy donor lungs. SevPH-COPD versus MildPH-COPD was characterized by better preserved forced vital capacity (51% vs 40% predicted, p < 0.05), less emphysema (MID 169 µm vs 279 µm, p < 0.001), and less PAS-positive and CD45-positive mucosa cells (15% vs 22%, p = 0.063% and 5% vs 7%, p = 0.058) suggesting less airway inflammation. In COPD patients, intimal and medial thickening were strongly correlated with mPAP (r = 0.676, p < 0.001 and r = 0.595, p < 0.001). MID was negatively correlated with mPAP (r = -0.556, p < 0.001) and was highest in NoPH-COPD (mean 281 µm), suggesting that emphysema per se is not associated with PH. CONCLUSIONS: End-stage COPD with severe PH is characterized by pronounced pulmonary vascular remodeling, less inflammation of small airways, and less emphysema as compared to COPD with mild PH or no PH, suggesting that COPD with severe PH may represent a unique phenotype of COPD.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Pulmonary Disease, Chronic Obstructive - physiopathology, complications, pathology
Male - administration & dosage
Female - administration & dosage
Hypertension, Pulmonary - physiopathology, etiology
Middle Aged - administration & dosage
Vascular Remodeling - physiology
Severity of Illness Index - administration & dosage
Aged - administration & dosage
Pulmonary Artery - pathology, physiopathology
Airway Remodeling - physiology
Lung - physiopathology, pathology
Retrospective Studies - administration & dosage

Find related publications in this database (Keywords)
histology
pulmonary hypertension
chronic obstructive pulmonary disease
remodeling
emphysema
© Med Uni GrazImprint